FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1824605490> ?p ?o ?g. }

• W1824605490 abstract "Cerebral toxoplasmosis or toxoplasmic meningoencephalitis (hereafter referred to as TE) was one of the first opportunistic infections to be described in human immunodeficiency virus (HIV) -infected patients. Treatment of TE has been relatively successful in comparison to other opportunistic infections. Prior to the introduction of highly active antiretroviral therapy (HAART), a median survival of over a year was reported for patients who could tolerate the toxicity of TE treatment. HAART is becoming increasingly widely available in sub-Saharan Africa, where the majority of HIV-infected patients live. Many patients in Africa are diagnosed with HIV only after developing opportunistic infections such as TE. Hence, the optimal management of opportunistic infections such as TE is important if the benefits of subsequently initiating HAART are to be seen.The purpose of this review is to determine the most effective therapy for TE in HIV-infected adults. Different treatment regimens have been compared with regard to clinical and radiological response, mortality, morbidity, and serious adverse events.A comprehensive search of relevant databases and other sources was conducted to identify relevant studies.Randomised double-blinded trials were included.Data were extracted using standardised forms and analysed using Rev Man 4.2.7 software.Three trials were found to meet the inclusion criteria. Dannemann et al 1992 and Katlama et al 1996 compared pyrimethamine plus sulfadiazine (P+S) with pyrimethamine plus clindamycin (P+C). Torre 1998 compared P+S with trimethoprim-sulfamethoxazole (TMP-SMX). For the purposes of this review, clinical outcomes were analysed as complete or partial resolution vs. failure. Patients who crossed over or were lost to follow-up were analysed as failures. Dannemann et al 1992 assessed 59 patients. Five of 26 (19%) patients randomised to P+C died in the first 6 weeks compared with 2 of the 33 (6%) patients randomised to P+S (relative risk (RR) 3.17; 95% CI 0.67-15.06). Complete or partial clinical response was obtained in 12 (46.2%) patients receiving P+C vs. 16 (48.5 %) patients receiving P+S (RR 0.95; 95% CI 0.55-1.64). Katlama et al 1996 assessed 299 patients. Twenty-nine (19%) of the 152 patients randomised to P+C died compared with 22 (15%) of the 147 patients randomised to P+S (RR 1.27; 95% CI 0.77-2.11). We were unable to obtain data on the outcomes of patients who crossed over and therefore excluded these data from the analysis. Dannemann et al 1992 and Katlama et al 1996 were analysed together for the outcome of death. The two treatment arms did not differ for death (RR 1.41; 95% CI 0.88-2.28). Torre et al 1998 assessed 77 patients. There were no deaths during the study period. Twenty-eight (70%) of 40 patients randomised to TMP-SMX had a complete or partial clinical response compared with 26 (70%) of 37 patients randomised to P+S (RR 1.0; 95% CI 0.74-1.33).The available evidence fails to identify any one superior regimen for the treatment of TE. The choice of therapy will often be directed by available therapy. Given the current evidence, TMP-SMX appears to be an effective alternative therapy for TE in resource-poor settings where P+S are not available." @default.
• W1824605490 created "2016-06-24" @default.
• W1824605490 creator A5044489418 @default.
• W1824605490 creator A5054604814 @default.
• W1824605490 date "2006-07-19" @default.
• W1824605490 modified "2023-09-27" @default.
• W1824605490 title "Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)" @default.
• W1824605490 cites W1899578539 @default.
• W1824605490 cites W1974282283 @default.
• W1824605490 cites W1980548213 @default.
• W1824605490 cites W1982137220 @default.
• W1824605490 cites W1985743144 @default.
• W1824605490 cites W1993471974 @default.
• W1824605490 cites W1996289032 @default.
• W1824605490 cites W2033907910 @default.
• W1824605490 cites W2044416560 @default.
• W1824605490 cites W2046105178 @default.
• W1824605490 cites W2049872810 @default.
• W1824605490 cites W2060379424 @default.
• W1824605490 cites W2124445355 @default.
• W1824605490 cites W2143764703 @default.
• W1824605490 cites W2146329405 @default.
• W1824605490 cites W2172059856 @default.
• W1824605490 cites W3025190738 @default.
• W1824605490 doi "https://doi.org/10.1002/14651858.cd005420.pub2" @default.
• W1824605490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16856096" @default.
• W1824605490 hasPublicationYear "2006" @default.
• W1824605490 type Work @default.
• W1824605490 sameAs 1824605490 @default.
• W1824605490 citedByCount "34" @default.
• W1824605490 countsByYear W18246054902012 @default.
• W1824605490 countsByYear W18246054902013 @default.
• W1824605490 countsByYear W18246054902014 @default.
• W1824605490 countsByYear W18246054902015 @default.
• W1824605490 countsByYear W18246054902016 @default.
• W1824605490 countsByYear W18246054902017 @default.
• W1824605490 countsByYear W18246054902018 @default.
• W1824605490 countsByYear W18246054902019 @default.
• W1824605490 countsByYear W18246054902020 @default.
• W1824605490 countsByYear W18246054902021 @default.
• W1824605490 crossrefType "journal-article" @default.
• W1824605490 hasAuthorship W1824605490A5044489418 @default.
• W1824605490 hasAuthorship W1824605490A5054604814 @default.
• W1824605490 hasConcept C119599485 @default.
• W1824605490 hasConcept C126322002 @default.
• W1824605490 hasConcept C127413603 @default.
• W1824605490 hasConcept C177713679 @default.
• W1824605490 hasConcept C187212893 @default.
• W1824605490 hasConcept C197934379 @default.
• W1824605490 hasConcept C203014093 @default.
• W1824605490 hasConcept C2522874641 @default.
• W1824605490 hasConcept C2776452011 @default.
• W1824605490 hasConcept C2777035104 @default.
• W1824605490 hasConcept C2778048844 @default.
• W1824605490 hasConcept C2778062946 @default.
• W1824605490 hasConcept C2778269047 @default.
• W1824605490 hasConcept C2778371730 @default.
• W1824605490 hasConcept C2779196057 @default.
• W1824605490 hasConcept C2780216070 @default.
• W1824605490 hasConcept C2780727368 @default.
• W1824605490 hasConcept C2780728791 @default.
• W1824605490 hasConcept C2909201284 @default.
• W1824605490 hasConcept C3013748606 @default.
• W1824605490 hasConcept C501593827 @default.
• W1824605490 hasConcept C535046627 @default.
• W1824605490 hasConcept C71924100 @default.
• W1824605490 hasConcept C761482 @default.
• W1824605490 hasConcept C83455156 @default.
• W1824605490 hasConcept C86803240 @default.
• W1824605490 hasConcept C89423630 @default.
• W1824605490 hasConceptScore W1824605490C119599485 @default.
• W1824605490 hasConceptScore W1824605490C126322002 @default.
• W1824605490 hasConceptScore W1824605490C127413603 @default.
• W1824605490 hasConceptScore W1824605490C177713679 @default.
• W1824605490 hasConceptScore W1824605490C187212893 @default.
• W1824605490 hasConceptScore W1824605490C197934379 @default.
• W1824605490 hasConceptScore W1824605490C203014093 @default.
• W1824605490 hasConceptScore W1824605490C2522874641 @default.
• W1824605490 hasConceptScore W1824605490C2776452011 @default.
• W1824605490 hasConceptScore W1824605490C2777035104 @default.
• W1824605490 hasConceptScore W1824605490C2778048844 @default.
• W1824605490 hasConceptScore W1824605490C2778062946 @default.
• W1824605490 hasConceptScore W1824605490C2778269047 @default.
• W1824605490 hasConceptScore W1824605490C2778371730 @default.
• W1824605490 hasConceptScore W1824605490C2779196057 @default.
• W1824605490 hasConceptScore W1824605490C2780216070 @default.
• W1824605490 hasConceptScore W1824605490C2780727368 @default.
• W1824605490 hasConceptScore W1824605490C2780728791 @default.
• W1824605490 hasConceptScore W1824605490C2909201284 @default.
• W1824605490 hasConceptScore W1824605490C3013748606 @default.
• W1824605490 hasConceptScore W1824605490C501593827 @default.
• W1824605490 hasConceptScore W1824605490C535046627 @default.
• W1824605490 hasConceptScore W1824605490C71924100 @default.
• W1824605490 hasConceptScore W1824605490C761482 @default.
• W1824605490 hasConceptScore W1824605490C83455156 @default.
• W1824605490 hasConceptScore W1824605490C86803240 @default.
• W1824605490 hasConceptScore W1824605490C89423630 @default.
• W1824605490 hasLocation W18246054901 @default.
• W1824605490 hasLocation W18246054902 @default.
• W1824605490 hasOpenAccess W1824605490 @default.

• next